Adaptimmune Therapeutics ADAPY
OTC ADAPY
$0.03 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Adaptimmune Therapeutics PLC (ADAPY) Non-Current Deffered Revenue (2015 - 2025)

Updated

Adaptimmune Therapeutics' Non-Current Deffered Revenue was $101.42 million in Q2 2025, up 1.6% from $99.86 million a year earlier and up 5.7% from the prior quarter.

Analysis

Adaptimmune Therapeutics PLC (ADAPY) Non-Current Deffered Revenue (2015 - 2025) Analysis & Trends

At the end of FY2024, Non-Current Deffered Revenue at Adaptimmune Therapeutics came in at $95.82 million, down 35.7% from FY2023.

  • Non-Current Deffered Revenue has now declined for three consecutive years, though with a four-year compound annual growth rate of 18.1% (FY2020 to FY2024).
  • In earlier years, Non-Current Deffered Revenue was $149.06 million in FY2023 (-7.4%), $160.89 million in FY2022 (-9.2%), $177.22 million in FY2021 (+259.8%) and $49.26 million in FY2020.
  • The Q2 2025 figure marks the highest quarterly Non-Current Deffered Revenue since Q1 2024.
  • Compared with a year earlier, Non-Current Deffered Revenue was higher in two of the last eight quarters, with an average decline of 11.8%.
  • The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q4 2021 (growth of 259.8%); the worst was Q4 2024 (a decline of 35.7%).
  • Per Business Quant data, ADAPY's Non-Current Deffered Revenue in the three quarters before Q2 2025 was $95.98 million (Q1 2025), $95.82 million (Q4 2024) and $98.73 million (Q3 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 101.42 Mn
Mar 31, 2025 95.98 Mn
Dec 31, 2024 95.82 Mn
Sep 30, 2024 98.73 Mn
Jun 30, 2024 99.86 Mn
Mar 31, 2024 147.37 Mn
Dec 31, 2023 149.06 Mn
Sep 30, 2023 111.49 Mn
Jun 30, 2023 117.26 Mn
Mar 31, 2023 119.25 Mn
Dec 31, 2022 160.89 Mn
Sep 30, 2022 132.23 Mn
Jun 30, 2022 150.44 Mn
Mar 31, 2022 166.61 Mn
Dec 31, 2021 177.22 Mn
Sep 30, 2021 47.04 Mn
Jun 30, 2021 50.05 Mn
Mar 31, 2021 50.57 Mn
Dec 31, 2020 49.26 Mn
Sep 30, 2020 46.21 Mn
API Access

Adaptimmune Therapeutics PLC Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ADAPY&period=max&api_key=YOUR_API_KEY